{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-034917","form_type":"8-K","ticker":"ARQT","cik":"0001787306","company_name":"Arcutis Biotherapeutics, Inc.","filed_at":"2023-10-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.447980+00:00","generated_at":"2026-06-09T17:03:27.890434+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Arcutis Biotherapeutics prices public offering of 32.5M shares and pre-funded warrants for ~$93.5M net","bullets":["Offering: 32.5M common shares at $2.50 each plus pre-funded warrants for 7.5M shares at $2.4999 each.","Net proceeds expected ~$93.5M after discounts and expenses; closing expected October 24, 2023.","Underwriters granted 30-day option to purchase up to 6M additional common shares.","Pre-funded warrants have $0.0001 exercise price and include 9.99% beneficial ownership limitation (adjustable to 19.99%)."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-034917","json":"https://secwatch.observer/filing/0001628280-23-034917.json","markdown":"https://secwatch.observer/filing/0001628280-23-034917.md","text":"https://secwatch.observer/filing/0001628280-23-034917.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1787306/000162828023034917/0001628280-23-034917-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1787306/000162828023034917/arqt-20231019.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T17:03:27.890434+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}